Tricho Hepato Enteric Syndrome Clinical Trial
— THE-RNAOfficial title:
Tricho-hepato-enteric Syndrome: From Abnormal RNA Decay to Disease Clinical and Biological Characterization of Patients and Collection of Samples -THE-RNA
Objectives: Collect clinical and biological data about patients with SD/THE, collect samples
of patients; create a secure on line database to collect worldwide data about SD/THE Partners
: APHM, HCL, APHP
Currently10 patients (8 with TTC37 mutations and 2 with SKIV2l mutations) present a SD/THE
and are managed in France in 5 different centers (Marseille, Paris Trousseau, Paris Necker,
Paris Robert Debrés, and Lyon). Most of them are followed in hepato-gastro-enterology units
for their intractable diarrhea. Three aspects of the disease: intractable diarrhea, immune
defect and liver disease are responsible for the main part of the burden of the disease .For
each aspect, the investigators will propose a close follow-up with collection of clinical,
biochemical, functional and microbial data.
Collect of clinical date: during a programmed consultation clinical data about symptom will
be collected twice a year. A detailed form will be used for better delineation of the
symptoms. These data included growth, symptom (diarrhea, pain …), and clinical signs. Most of
these children have recurrent sample for follow up. During them some blood will be take for
study the immune side but also the platelet function.
| Status | Not yet recruiting |
| Enrollment | 100 |
| Est. completion date | December 31, 2023 |
| Est. primary completion date | August 31, 2023 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - patient < 18 year-old - patients with SD/THE control group : - patients with tufting enteropathy and short bowel syndrome. Exclusion Criteria: - child among whom the parents or the legal representatives refused that their child participates in this study |
| Country | Name | City | State |
|---|---|---|---|
| France | Assistance Publique Hopitaux de Marseille | Marseille |
| Lead Sponsor | Collaborator |
|---|---|
| Assistance Publique Hopitaux De Marseille |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Assessment of detailed clinical characteristics of the phenotype of Tricho-hepato-enteric syndrome | Existence or absence of 9 clinical signs suggestive of Tricho-hepato-enteric syndrome, to know: neonatal characteristics, existence or not of the 9 clinical signs suggestive of the disease, initial symptoms and chronology leading to the diagnosis, organ damage, nutrition, treatment, growth, dermatological evaluation, hepatic evaluation, neuropsychological evaluation (score of WPPSI-III, WISC-IV, WAIS-IV), quality of life scale (VSPA in children between 3 and 17 years old and WHOQUOL in adults), self-report anxiety scale (STAI in children over 8 years) |
3 years |